ACP
TMO icon

Argyle Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Argyle Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$361K Buy
720
+83
+13% +$39.8K 0.23% 118
2026
Q1 		$313K Buy
637
+111
+21% +$60.2K 0.23% 118
2025
Q4 		$305K Sell
526
-139
-21% -$78.6K 0.22% 117
2025
Q3 		$322K Sell
665
-140
-17% -$65.2K 0.23% 120
2025
Q2 		$326K Buy
+805
New +$337K 0.27% 105

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Argyle Capital Partners's TMO Position: Q2 2026 in Review

Argyle Capital Partners increased its Thermo Fisher Scientific (TMO) stake by 13% in Q2 2026, buying an estimated $39.8K and bringing the position to 720 shares worth $361K. The position accounts for 0.23% of the portfolio, ranked #118.

Argyle Capital Partners first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Argyle Capital Partners held 720 shares of Thermo Fisher Scientific worth $361K as of Q2 2026.
  • Argyle Capital Partners bought 83 Thermo Fisher Scientific shares in Q2 2026, an estimated $39.8K.
  • Thermo Fisher Scientific made up 0.23% of Argyle Capital Partners's portfolio in Q2 2026, its #118 holding.
  • Argyle Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Argyle Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.